Filter
412
Text search:
Antimalarial
treatment
policy
Featured
Recommendations
40
New Publications
168
Language
Document type
No document type
251
Studies & Reports
58
Guidelines
41
Manuals
21
Strategic & Response Plan
16
Training Material
13
Fact sheets
9
Situation Updates
2
Resource Platforms
1
Countries / Regions
Uganda
24
Global
21
Kenya
19
India
17
Liberia
16
Ghana
16
Malawi
16
Nigeria
14
Tanzania
14
Sierra Leone
13
Ethiopia
11
Zambia
11
Rwanda
10
Africa
8
Zimbabwe
7
Latin America and the Carribbean
7
Senegal
6
Namibia
6
Nepal
5
Cambodia
5
Bangladesh
5
Mozambique
5
South–East Asia Region
5
Cameroon
4
Myanmar / Burma
4
Philippines
3
Thailand
3
Indonesia
3
South Africa
3
Eswatini/ Swaziland
3
West and Central Africa
3
Vietnam
3
Burkina Faso
2
Congo, Democratic Republic of
2
Haiti
2
Somalia
2
South Sudan
2
China
2
Botswana
2
Madagascar
2
East and Southern Africa
2
Paraguay
2
Asia
2
Venezuela
2
Laos
2
North America
2
Guinea
1
Mali
1
Pakistan
1
Lebanon
1
Sudan
1
Benin
1
Dominican Republic
1
Honduras
1
El Salvador
1
Libya
1
Guatemala
1
Nicaragua
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Western and Central Europe
1
Southern Africa
1
Timor Leste/ East Timor
1
Belize
1
Costa Rica
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
252
Clinical Guidelines
34
Women & Child Health
26
Public Health
16
Capacity Building
13
Key Resources
11
Pharmacy & Technologies
8
Toolboxes
Malaria
70
Pharmacy
17
AMR
16
Ebola & Marburg
8
HIV
8
COVID-19
6
Caregiver
5
Conflict
3
Rapid Response
3
Mental Health
3
NTDs
3
Health Financing Toolbox
3
2.0 Rapid Response
3
TB
2
Planetary Health
2
Cholera
1
Global Health Education
1
Combination therapy is a cornerstone of modern malaria treatment, particularly in the context of widespread multidrug resistance. Using two or more antimalarial drugs with different mechanisms simul
...
Revised Edition
Prompt, effective antimalarial treatment, and supportive care can substantially reduce the rate of mortality from severe malaria. However, many children in malaria-endemic countries do not have acce
...
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies o
...
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria tre
...
World Health Organization Country profiles 2017
The reports bring together the latest findings and conclusions about the state of resistance to artemisinins and artemisinin-based combination therapy (ACT), summarize WHO’s current policy and treatment
...
Malaria remains a significant public health concern in the SADC region, accounting for 20% of childhood deaths, as well as prompting numerous outpatient visits and hospitalisations. Around three-quarters of the population, including 35 million children under the age of five and 8.5 million pregnant
...
Zambia has recognised the Public Health threat of antimicrobial resistance and its impact on morbidity and mortality, as well as the subsequent economic consequences. The country has recorded microorganisms which have developed resistance to antimicrobial drugs. Notable among these are; Multidrug Re
...
The overall goal of the programme, to reduce the malaria morbidity and mortality by 75% (using 2012 as baseline) by the year 2020, continued to be pursued in 2014. The following areas were identified as some of the priorities for the year: Malaria Case Management under which we have Malaria in Pregn
...
Master of Science in Pharmaceutical Management Dissertation
Information note. In 2021, preliminary results of observational studies from the Community Access to Rectal Artesunate for Malaria (CARAMAL) project did not confirm the mortality impact observed in the controlled trial in 2009. Consequently, in January 2022, WHO released an information note on recta
...
Launch of the WHO Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010–2019). Key findings
